A paternalistic approach to treatment planning is common, but there a growing interest in involving clients the of their own treatment, both medical care and psychotherapy. Several studies on matching patients have failed improve outcome. Studies Shared Decision-Making mental health are encouraging somewhat ambiguous addiction treatment. This study investigated whether self-matching (Informed C...

The effects of intergenerational trauma, colonization, and genocide are numerous include higher rates health disparities such as substance use. purpose this research is to identify areas resilience empowerment in addiction recovery among Indigenous Peoples living Saskatchewan, Canada. Community approval was sought from the Research Advisory Committee network sampling used for co-researcher recr...

BACKGROUND Use of methadone for the treatment of opioid addiction is an effective harm-reduction approach, although variability in treatment outcomes among individuals has been reported. Men and women with opioid addiction have been known to differ in factors such as opioid use patterns and characteristics at treatment entry; however, little has been reported about differences in methadone trea...

BACKGROUND There is on-going controversy in relation to the efficacy of naltrexone used for the treatment of heroin addiction, and the important covariates of that success. We were also interested to review our experience with two depot forms of implantable naltrexone. METHODS A retrospective review of patients' charts was undertaken, patients were recalled by telephone and by letter, and uri...

BACKGROUND In many countries, buprenorphine and methadone are licensed for the maintenance treatment (MT) of opioid dependence. Despite many short-term studies, little is known about the long-term (12-month) effects of these treatments in different settings, i.e. primary care-based (PMC) and specialized substitution centers (SSCs). OBJECTIVES To describe over a period of 12 months: (1) mortal...

The purpose of this study was to investigate the effects of methadone treatment and buprenorphine treatment on retention in treatment, urine drug testing results, psychiatric status, social adjustment, and quality of life among patients involved in long-term treatment with the cited medications. Two hundred thirteen patients (106 on buprenorphine treatment and 107 on methadone treatment) were e...

BACKGROUND The opioid receptor antagonists naloxone and naltrexone are competitive antagonists at the mu, kappa, and sigma receptors with a higher affinity for the mu receptor and lacking any mu receptor efficacy. Buprenorphine is classified as a partial agonist. It has a high affinity, but low efficacy at the mu receptor where it yields a partial effect upon binding. It also, however, possesse...